Key result
Transesophageal echocardiography during cardiac surgery provided substantial financial benefits, saving ~$600 per case in congenital heart disease and ~$450 per case in valvular repair.
Why the study?
Is transesophageal echocardiography cost-effective during and after cardiac surgery?
Population
Patients requiring cardiac surgery
Design
Other
Authors
Loading...
May support selective use in congenital and valvular repair cases; leaves open broader adoption pending prospective trials.
Is transesophageal echocardiography cost-effective during and after cardiac surgery?
Transesophageal echocardiography during cardiac surgery is generally cost-effective, particularly for congenital heart disease and valvular repair, though it may represent a net cost in valve replacement.
BENSON et al. (1995) studied Cardiac surgery. Transesophageal Echocardiography (TEE) was evaluated on Costs and outcomes (money and lives saved). Transesophageal echocardiography during cardiac surgery provided substantial financial benefits, saving ~$600 per case in congenital heart disease and ~$450 per case in valvular repair.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: